Antti Jekunen Selected Research

tasidotin

11/2005	Phase I and pharmacokinetic study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously on days 1, 3, and 5 every 3 weeks in patients with advanced solid tumors.
11/2005	A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antti Jekunen Research Topics

Disease

8	Neoplasms (Cancer) 09/2021 - 11/2005
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2020
2	Neoplasm Metastasis (Metastasis) 09/2021 - 04/2021
2	Nausea 11/2005 - 11/2005
2	Fatigue 11/2005 - 11/2005
2	Alopecia (Baldness) 11/2005 - 11/2005
1	Colorectal Neoplasms (Colorectal Cancer) 09/2021
1	Cicatrix (Scar) 09/2021
1	Adenocarcinoma 09/2021
1	Dihydropyrimidine Dehydrogenase Deficiency 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Circulating Neoplastic Cells 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Ileus 11/2005
1	Melanoma (Melanoma, Malignant) 11/2005
1	Diarrhea 11/2005
1	Neutropenia 11/2005
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2005
1	Edema (Dropsy) 11/2005
1	Anorexia 11/2005
1	Anemia 11/2005
1	Vomiting 11/2005

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2021 - 11/2005
2	tasidotinIBA 11/2005 - 11/2005
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2021
1	Panitumumab (Vectibix)FDA Link 09/2021
1	UracilIBA 01/2021
1	EnzymesIBA 01/2021
1	Capecitabine (Xeloda)FDA Link 01/2021
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	cabazitaxel FDA Link 12/2020
1	Docetaxel (Taxotere)FDA Link 12/2020
1	Tyrosine Kinase InhibitorsIBA 10/2019
1	Sunitinib (Sutent)FDA Link 10/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2019
1	Transaminases (Aminotransferases)IBA 11/2005
1	Alanine Transaminase (SGPT)IBA 11/2005
1	Aspartic Acid (Aspartate)FDA Link 11/2005

Therapy/Procedure

5	Therapeutics 09/2021 - 01/2014
2	Radiotherapy 01/2022 - 09/2021
2	Drug Therapy (Chemotherapy) 09/2021 - 01/2016
1	Combined Modality Therapy 09/2021
1	Precision Medicine 09/2021
1	Combination Drug Therapy (Combination Chemotherapy) 09/2021
1	Metastasectomy 04/2021
1	Castration 12/2020